6.37
Immucell Corp Azioni (ICCC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
14.57%
5.5061
|
6.4449 | 8.0672 | 7.7511 | 6.0116 |
| Cost Of Revenue |
13.34%
3.143
|
3.627 | 4.7132 | 4.9195 | 4.428 |
| Gross Profit |
16.14%
2.3631
|
2.8179 | 3.354 | 2.8316 | 1.5836 |
|
|
4.21%
2.343
|
2.2484 | 2.2363 | 2.2103 | 2.1584 |
| Benefits Costs and Expenses |
5.04%
5.6414
|
5.9411 | 6.6183 | 7.2305 | 6.7119 |
| Costs And Expenses |
5.04%
5.6414
|
5.9411 | 6.6183 | 7.2305 | 6.7119 |
| Operating Income/Loss |
96.48%
0.0201
|
0.5696 | 1.1176 | 0.6214 | -0.5749 |
| Nonoperating Income/Loss |
136.20%
-0.1554
|
-0.0658 | 0.3313 | -0.1008 | -0.1255 |
| Income/Loss From Continuing Operations Before Tax |
126.86%
-0.1353
|
0.5038 | 1.4489 | 0.5206 | -0.7004 |
| Income Tax Expense/Benefit |
134.03%
0.00446
|
0.0019 | 0.0019 | 0.00604 | 0.00134 |
| Income/Loss From Continuing Operations After Tax |
127.84%
-0.1397
|
0.5019 | 1.447 | 0.5146 | -0.7017 |
|
|
127.84%
-0.1397
|
0.5019 | 1.447 | 0.5146 | -0.7017 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.16%
9.0459
|
9.0313 | 8.9806 | 0.2588 | 8.1644 |
| Diluted Average Shares |
0.16%
9.0459
|
9.0313 | 8.9806 | 0.2588 | 8.1644 |
| Basic Earnings Per Share |
133.33%
-0.02
|
0.06 | 0.16 | 0.08 | -0.09 |
| Diluted Earnings Per Share |
133.33%
-0.02
|
0.06 | 0.16 | 0.08 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):